Home / Products / Cancer (Tumor) Cell Lines / RPMI-2650
RPMI-2650
Datasheet Protocol

RPMI-2650

Cat. No. ARC0781
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Nose (nasal septum)

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

RPMI-2650 is a cancer cell line of nose (nasal septum) nut carcinoma, isolated from metastatic; pleural effusion.

Recommended Products

ASAH1 Knockout K562 Polyclonal Cells ASAH1 Knockout K562 Polyclonal Cells Cat. No. ARG20222 AFTPH Knockout Raji Polyclonal Cells AFTPH Knockout Raji Polyclonal Cells Cat. No. ARG21085 AP1AR Knockout HGC-27 Polyclonal Cells AP1AR Knockout HGC-27 Polyclonal Cells Cat. No. ARG29550 HNRNPAB Knockout HT29 Polyclonal Cells HNRNPAB Knockout HT29 Polyclonal Cells Cat. No. ARG33367 GCLC Knockout HEK293T Polyclonal Cells GCLC Knockout HEK293T Polyclonal Cells Cat. No. ARG4648 NF1 Knockout AGS Polyclonal Cells NF1 Knockout AGS Polyclonal Cells Cat. No. ARG2149
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Nose (nasal septum)
Disease:
NUT carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
52 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CAPN1 Knockout K562 Polyclonal Cells

CAPN1 Knockout K562 Polyclonal Cells

Cat. No. ARG20387
 ETFB Knockout A549 Polyclonal Cells

ETFB Knockout A549 Polyclonal Cells

Cat. No. ARG10895
 CRTAP Knockout Hela Polyclonal Cells

CRTAP Knockout Hela Polyclonal Cells

Cat. No. ARG7924
 HSD17B4 Knockout Hela Polyclonal Cells

HSD17B4 Knockout Hela Polyclonal Cells

Cat. No. ARG37555
 DCAF11 Knockout HEK293T Polyclonal Cells

DCAF11 Knockout HEK293T Polyclonal Cells

Cat. No. ARG4353
 MLH1 Knockout Raji Polyclonal Cells

MLH1 Knockout Raji Polyclonal Cells

Cat. No. ARG1941